Skip to main content

Table 6 Risk for glycometabolism disorder (T2DM and pre-diabetes) in different group classified by VFA/BFP/WC and BMI

From: Visceral fat area and body fat percentage measured by bioelectrical impedance analysis correlate with glycometabolism

Groups

Risk for glycometabolism disorder (OR (95% CI) p-value)

Grouped by VFA and BMI

Grouped by BFP and BMI

Grouped by WC and BMI

1

reference

reference

reference

2

1.615 (1.267, 2.058) < 0.001

1.248 (0.909, 1.712) 0.170

1.025 (0.376, 2.797) 0.961

3

1.229 (1.130, 1.338) < 0.001

1.160 (1.078, 1.248) < 0.001

1.256 (1.168, 1.349) < 0.001

4

1.617 (1.460, 1.790) < 0.001

1.674 (1.511, 1.855) < 0.001

1.764 (1.590, 1.958) < 0.001

  1. Group 1:non-excessive BMI and non-excessive VFA/BFP/WC; Group 2: non-excessive BMI and VFA/BFP/WC obesity; Group 3: non-excessive VFA/BFP/WC and BMI obesity. Group 4: BMI obesity and VFA/BFP/WC obesity. Normal = 0, T2DM and Prediabetes = 1. Age, sex, HBP, TG, TC, LDL-c, HDL-c and SUA were adjusted. SUA Serum uric acid, HbA1c Glycosylated hemoglobin, FBG Fasting blood glucose, HBP High blood pressure, HDL-c High density lipoprotein cholesterol, LDL-c Low density lipoprotein cholesterol, TC Total cholesterol, TG Triglyceride, BMI Body mass index, VFA Visceral fat area, BFP Body fat percentage, WC Waist circumference, T2DM Type 2 diabetes mellitus
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us